FDA
approval
· 2009-02-13
FDA Approved: ULORIC — Original Application (Takeda Pharmaceuticals America, Inc.)
Summary
FDA approved ULORIC (febuxostat) as the original application to treat hyperuricemia associated with gout by lowering serum uric acid levels. The product is manu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ULORIC (FEBUXOSTAT)